Accelerate Brain Cancer Cure
The organization Accelerate Brain Cancer Cure (ABC2) funds the development of new treatments and also offers information about patient care, clinical trials and research advances for brain cancer patients.
You May Also Like:
AACR Virtual Annual Meeting I: Using Biomarkers to Predict Responses to Immune Checkpoint Inhibitors
Learn MoreApril Editors’ Picks from AACR Journals
Learn MoreAACR Virtual Annual Meeting II: Understanding Racial Disparities in Cancer
Learn MoreMolecular Targets 2021: Getting CRISPR Where It Needs to Go
Learn MoreFDA Approvals in Oncology: January-March 2024
Learn MoreNew Immune Checkpoint Inhibitor Approved for Bladder Cancer
Learn MoreFDA Approves a New PARP Inhibitor for BRCA-mutant Breast Cancer
Learn MoreAACR Congratulates Jim Allison on Nobel Prize
Learn More
The More You Know About Cancer Prevention
Learn MoreAACR Virtual Annual Meeting I: The Promises and Challenges of Expanding the Use of Immune Checkpoint Inhibitors Through Combination Therapy
Learn More